台股 » 個股 » 中裕 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

中裕

(4147)
可現股當沖
  • 股價
    77.8
  • 漲跌
    ▼1.1
  • 漲幅
    -1.39%
  • 成交量
    475
  • 產業
    上櫃 生技醫療類股
  • 321人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
中裕 (4147)籌碼相關-華南永昌-朴子 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw06/0806/2207/0607/2208/0208/1608/3009/1409/2810/1210/2611/0811/2212/0612/2001/0401/1802/0802/2203/0803/1803/2804/1004/2004/3005/1205/1460708090100110Jul '24Sep '24Nov '24Mar '25May '2560d90dAll

華南永昌-朴子 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/05/0700.00078.3079.0001,8700.00%
2025/05/0600.00780.1980.20-71,873-0.37%
2025/05/0200.00581.8081.70-51,874-0.27%
2025/04/2500.00180.1080.00-11,873-0.05%
2025/04/24579.6000.0079.6051,8790.27%
2025/04/1000.00073.4073.4002,3720.00%
2025/04/09167.60074.0066.8012,3770.04%
2025/04/080.172.3000.0071.300.12,3310.00%
2025/03/27096.6000.0096.1002,2480.00%
2025/03/2400.00399.5099.00-32,192-0.14%
2025/03/19092.8000.0092.8002,0980.00%
2025/03/131591.721591.6091.6002,0990.00%
2025/03/123096.9800.0097.50302,0601.46%
2025/03/10397.3000.0097.8032,0160.15%
2025/03/07095.4000.0096.5001,9910.00%
2025/03/05297.5000.0098.6021,9240.10%
2025/02/2500.005100.0099.30-51,856-0.27%
2025/02/2100.003103.5098.90-31,727-0.17%
2025/02/2000.00199.2099.70-11,553-0.06%
2025/02/176101.722105.0097.1041,4400.28%
2025/02/14199.89199.1098.9001,2260.00%
2025/02/1300.00293.9094.00-21,152-0.17%
2025/02/1200.00492.7093.00-41,152-0.35%
2025/02/10089.5000.0089.9001,1290.00%
2025/01/20283.8000.0084.2021,1360.18%
2025/01/1600.00187.1086.50-11,133-0.09%
2025/01/1000.003390.4090.50-331,064-3.10%
2025/01/08299.103101.0097.20-1872-0.11%
2025/01/0600.00190.8089.80-1611-0.16%
2025/01/03188.4000.0088.3016000.17%
2024/12/1800.001082.7582.90-10626-1.60%
2024/12/1700.00181.7082.00-1625-0.16%
2024/12/1600.001082.5581.80-10631-1.58%
2024/12/09188.9000.0090.1016000.17%
2024/12/06189.50288.7087.60-1573-0.17%
2024/12/0300.00285.4084.30-2529-0.38%
2024/11/1100.00080.0082.4005330.00%
2024/11/05581.6000.0081.6055370.93%
2024/11/041082.2200.0081.60105791.73%
2024/10/301082.2500.0081.40106011.66%
2024/10/2500.00281.8081.40-2567-0.35%
2024/10/2400.00181.8080.80-1572-0.17%
2024/10/23181.7000.0081.8015700.18%
2024/10/2200.00180.7080.60-1562-0.18%
2024/09/1000.00079.8079.9006930.00%
2024/08/1500.001079.9080.00-10775-1.29%
2024/08/08576.3000.0076.7057830.64%
2024/08/061568.9200.0070.30157711.94%
2024/08/051576.3700.0074.00157342.04%
2024/08/02883.4600.0082.2087081.13%
2024/07/31582.8000.0082.6057320.68%
2024/07/30283.5000.0083.9027370.27%
2024/07/292083.4500.0082.60207412.70%
2024/07/19190.00186.5086.5007270.00%
2024/07/0300.002088.0087.40-20953-2.10%
2024/06/11193.20292.2591.00-11,182-0.08%
2024/06/07188.40190.4090.1001,1670.00%
2024/06/0500.00190.7090.30-11,237-0.08%
2024/05/30589.1400.0088.6051,4750.34%
2024/05/23189.1000.0087.1012,0140.05%
2024/05/21989.20488.2088.0052,1230.24%
2024/05/201387.3800.0087.20132,1300.61%
2024/05/17787.7300.0087.7072,1700.32%
2024/05/16585.9600.0086.9052,1890.23%
2024/05/151086.6500.0086.40102,2110.45%
中裕首度與美國客戶簽訂CDMO合約 營運添動能Anue鉅亨-13天前
〈美對等關稅〉中裕回應暫無影響 愛滋病新藥足以供應美國市場銷售Anue鉅亨-2025/04/09
中裕長效愛滋療法主要指標達標 啟動國際授權合作Anue鉅亨-2025/03/26
中裕 相關文章